Hemangiopericytoma-associated hypoglycemia improved by glucocorticoid therapy: A case report

Endocrine

Volumn 36, Issue 1, 2009, Pages 151-154

  Anaforoglu, Inan ^a   Simsek, Alimdar ^a   Turan, Turhan ^a   Algün, Ekrem ^a  

^a Trabzon Numune Training and Research Hospital   (Turkey)

Author keywords

Hemangiopericytoma; Hypoglycemia; IGF II; Nonislet cell tumor induced hypoglycemia

Indexed keywords

GLUCOCORTICOID;

ARTICLE; CASE REPORT; HEMANGIOPERICYTOMA; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; LUNG TUMOR; MALE; MENINGIOMA; METASTASIS; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY;

GLUCOCORTICOIDS; HEMANGIOPERICYTOMA; HUMANS; HYPOGLYCEMIA; LUNG NEOPLASMS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; PANCREATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 70349568487     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-009-9197-8     Document Type: Article

References (11)

1. S.W. Weiss, J.R. Goldblum (eds.), Enzinger's and Weiss's Soft Tissue Tumors (Academic, ST. Louis, 2001)
2. A.P. Stout, M.R. Murray, Hemangiopericytoma: A vascular tumor featuring Zimmerman's pericytes. Ann. Surg. 116, 26-33 (1942)
3. J.W. Howard, P.L. Davis, Retroperitoneal hemangiopericytoma associated with hypoglycemia and masculinization. Delaware Med. J. 31, 29-34 (1959)
4. K. Pavelić, S. Spaventi, V. Gluncić, A. Matejcić, D. Pavicić, N. Karapandza, Z. Kusić, J. Lukac, C. Dohoczky, T. Cabrijan, J. Pavelić, The expression, role of insulin-like growth factor II in malignant hemangiopericytomas. J. Mol. Med. 77, 865-869 (1999)
5. J.W. de Groot, B. Rikhof, J. van Doorn, H.J. Bilo, M.A. Alleman, A.H. Honkoop, W.T. van der Graaf, Non-islet cell tumour induced hypoglycemia: A review of the literature including two new cases. Endocr. Relat. Cancer 14, 979-993 (2007)
6. N. Hizuka, I. Fukuda, K. Takano, Y. Okubo, K. Asakawa-Yasumoto, K. Demura, Serum insulin-like growth factor in 44 patients with non-islet cell tumor hypoglycemia. Endocr. J. 45(Suppl), S61-S65 (1998)
7. W.H. Daughaday, B. Trivedi, R.C. Baxter, Abnormal serum IGFII transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II. Endocrine 3, 425-428 (1995)
8. I. Fukuda, N. Hizuka, Y. Ishikawa, K. Yasumoto, Y. Murakami, A. Sata, J. Morita, M. Kurimoto, Y. Okubo, K. Takano, Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm. IGF Res. 16, 211-216 (2006)
9. J.M. Guettier, P. Gorden, Hypoglycemia. Endocrinol. Metab. Clin. North Am. 35(753-766), viii-ix (2006)
10. F.J. Service, Hypoglycemic disorders. N. Engl. J. Med. 332, 1144-1152 (1995)
11. J.D. Teale, G. Wark, The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. Clin. Endocrinol. (Oxf) 60, 457-460 (2004)